Litcius/Paper detail

Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod

Magdalena Krbot Skorić, Dunja Rogić, Ivana Lapić, Dragana Šegulja, Mario Habek

2021Multiple Sclerosis and Related Disorders17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationTiterMultiple sclerosisImmunologyAntibody titerAntibodyCoronavirus disease 2019 (COVID-19)Immune systemVirologyInternal medicineDiseaseInfectious disease (medical specialty)Multiple Sclerosis Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod | Litcius